Bulletin of Mathematical Biology

We develop a novel individual-based population dynamics model of academic career progression, using 15 years of data from over 1,000 academics from one university. Our model improves on previous models, which, by homogenising career progression, may underestimate the costs of being female. We find multiple effects that compound to slow career progression for women. Women are hired at lower ranks than men, then face the sticky floor problem of getting stuck at the bottom for longer. Further, individuals in STEM fields are promoted more quickly; this disproportionately affects women who are more prevalent in non-STEM fields. Our model reveals age is more complicated than others have found with ODE-based models. Women are older when hired, and promotions favour the young; hence age costs women more. Finally, the probability of attrition rises with years spent at the same rank, regardless of gender. Since women are promoted slower, they experience higher attrition rates. We also deploy our model to test possible interventions. We find just hiring more women will not work. A more nuanced set of interventions is required. Gender parity will only be achieved at the highest ranks if hiring rates are jointly equalised across gender, academic rank, and discipline.

Melanoma is a cancer of the melanocyte, known to have an ability to readily switch between different transcriptional cell states that convey different phenotypic properties (e.g. hyper-differentiated, neural crest-like). This ability is believed to underpin intratumour heterogeneity and plastic adaptation, which contributes to resistance to therapy and immune evasion of the tumour. Therefore, understanding the mechanisms underlying acquisition of transcriptional cell states and cell-state switching is crucial for the development of therapies. We model a minimal gene regulatory network comprising three key transcription factors, whose varying gene expression encodes different melanoma cell states, and use deterministic spatiotemporal differential-equation models to study gene-expression dynamics. We exploit an approximation, based on cooperative binding of transcription factors, in which the models are piecewise-linear. We classify stable states of the local model in a biologically relevant manner and, using a naive model of intercellular communication, we explore how a population of cells can take on a shared characteristic through travelling waves of gene expression. We derive a condition determining which characteristic will become dominant, under sufficiently strong cell-cell signalling, which creates a partition of parameter space.

Cancer-associated fibroblasts (CAFs) are a central component of the tumor microenvironment that facilitate a supportive niche for cancer progression and metastasis. Experimental evidence suggests that CAFs can facilitate estrogen-independent tumor growth, thereby reducing the efficacy of anti-hormonal therapies. Understanding and quantifying the complex interactions between tumor cells, hormonal signalling, and the microenvironment are crucial for designing more effective and individualized treatment strategies. We propose a mathematical framework to explore the influence of CAFs on ER+ breast cancer progression and to evaluate strategies to mitigate their impact. We develop a system of nonlinear ordinary differential equations that substantiates the experimental observations by providing a mechanistic basis for the role of CAFs in regulating estrogen-independent growth dynamics. We then employ optimal control theory to evaluate distinct therapeutic approaches involving monotherapy or combinations of: (i) inhibition of tumor-to-CAF signaling, (ii) inhibition of CAF-to-tumor proliferative signaling, and (iii) endocrine therapy. Taken together, our results demonstrate that CAF-targeted strategies can enhance treatment efficacy across various estrogen dosing regimens. Our study provides new insights into the potential of CAF as a therapeutic target that could help to improve existing approaches for endocrine therapies.

Vaccine-acquired immunity plays an important role in controlling the spread of many infectious diseases; however, vaccine efficacy can diminish over time. This work uses a mathematical model to study the effects of waning vaccination-acquired immunity on infection incidence. With an SEIR-type compartmental model that considers both vaccinated and unvaccinated populations (and their mixing), we present mathematical conditions under which vaccinated individuals drive ongoing growth in infections, i.e., over half of the daily incidence arises from vaccinated individuals. Analysis of a mathematical model of COVID-19 spread in the state of Colorado suggests how and for what duration vaccinated individuals could have sustained such growth. Importantly, our model demonstrates that, despite potential for brief vaccinated-driven periods of growth in infections, which occur among unvaccinated-driven periods of growth in infections, increased vaccination coverage always reduces total cases and total hospitalizations. This work provides insight into how waning immunity in vaccinated populations can contribute to ongoing infection incidence and demonstrates the value of complementary interventions to prevent disease spread in vaccinated populations.

1Although resources are typically distributed continuously in space, species distributions often organize into discrete clusters. In his seminal paper [36], Turing demonstrated that such clusters can spontaneously arise in population densities, even when populations evolve in environments with continuously varying conditions. This phenomenon is known as Turing instability. In this work, we focus on two models grounded in population dynamics: a one-dimensional model based on the nonlocal Fisher-KPP equation, and a two-dimensional model involving an environmental gradient. We show that phenotypic clusters (sometimes referred to as "species") emerge in these models. We prove that they do not emerge because of Turing instability, but because of stochasticity, and that they disappear when stochasticity is reduced. First, for both models, we start our simulations with initial populations uniformly distributed in the state space. We show that phenotypic clusters quickly emerge and that the distances between them depend on the population size, that is, on the degree of stochasticity. Next, we start from already clearly defined phenotypic clusters. We identify three regimes in the connection between population size, the initial distances between clusters, and the distances between clusters at equilibrium. Last, on the two-dimensional model, we relax the hypothesis of complete clonality by varying the effective recombination rate, explore its effect on phenotypic clustering, and show that phenotypic clustering decays drastically with slight recombination.

Within many bacterial colonies, persister cells exist as a subpopulation that is tolerant to antibiotics and other stressors, yet not genetically distinct from the rest of the colony. A recent study has proposed epigenetic inheritance as a mechanism that leads to the presence of persister cells. We analyze a nonlocal PDE-ODE model introduced in that study to describe the epigenetic inheritance process and establish its mathematical well-posedness, including existence, uniqueness, and nonnegativity of solutions. We identify a sharp parameter threshold delineating extinction from persistence of the colony: below this threshold the washout equilibrium is globally asymptotically stable, while above it a unique positive equilibrium exists and the population is weakly persistent. Notably, this threshold is independent of the internal community structure.

Experimental studies show that tumor cells adopt migratory or proliferative phenotypes depending on the local extracellular matrix (ECM). In this work, we propose a minimal go-or-grow invasion model, comprising two specialist cell phenotypes: proliferating and migratory, with phenotypic switching and cell migration depending on local ECM density. Numerical simulations of this model reveal that the spatial arrangement of proliferative and migratory cells depends on the choice of phenotypic switching function. We then ask whether this specialist cell-phenotype model can be reduced to a generalist cell-phenotype model. We derive a relationship between the reduced model and go-or-grow model in the fast phenotypic switching regime. We observe that the reduced model captures the dynamics of the original model, for a range of realistic phenotypic switching functions. We analytically derive the minimum traveling wave speed of the reduced model in a homogeneous ECM bed. Moreover, using linear stability analysis on the go-or-grow model, we recover the same wave speed expression. In addition, we numerically explore how the key parameters influence the traveling wave speed profile. Our analysis indicated the counter-intuitive result that the wave speed is independent of the matrix degradation rate, and our simulations show that, at most, the speed is weakly dependent on this parameter.

Standard target-mediated drug disposition (TMDD) models are widely used to describe nonlinear pharmacokinetics driven by high-affinity drug-target interactions. However, their reliance on instantaneous binding limits their ability to capture delayed and history-dependent dynamics observed in vivo. Here, we introduce a fractional TMDD model that incorporates memory effects through a fractional derivative, thereby generalizing the standard TMDD (sTMDD) framework. Although this fractional TMDD (fTMDD) formulation increases modeling flexibility, it also exacerbates parameter identifiability challenges under typical experimental conditions where only drug concentration data are available. To address this limitation, we derive a fractional quasi-steady-state approximation (fQSSA) that reduces model dimensionality while preserving essential nonlinear and memory-dependent pharmacokinetic dynamics. We further establish an explicit validity condition that quantifies the approximation error of both fTMDD and fQSSA without requiring numerical simulation. This condition reveals that the initial drug-to-target ratio is the primary determinant of QSSA validity, whereas the fractional order has a comparatively minor influence. Application of the proposed framework to recombinant human erythropoietin (rhEPO) data demonstrates that fractional dynamics play a population-dependent role, improving model performance in adults but not in infants. Together, this work provides the first systematic derivation of a QSSA framework for fractional TMDD models, along with rigorous and computable applicability conditions. Our results establish a principled foundation for incorporating memory effects into pharmacokinetic modeling and offer a generalizable framework for nonlinear PK-PD systems involving binding-mediated dynamics. Author summaryMany drugs interact strongly with their biological targets, leading to complex and nonlinear pharmacokinetics that are commonly described using target-mediated drug disposition (TMDD) models. However, these models assume that drug-target interactions occur instantaneously, which limits their ability to capture delayed and history-dependent behaviors observed in real biological systems. In this study, we develop a new modeling framework that incorporates such memory effects by extending TMDD models using fractional calculus. To make the model more practical and computationally efficient, we derive a simplified version based on a quasi-steady-state approximation (QSSA) and provide a clear mathematical condition that determines when this simplification is valid. Our analysis shows that the accuracy of the simplified model is primarily controlled by the initial ratio of drug to target, while the influence of memory effects is comparatively smaller. When applied to experimental data for erythropoietin, our model reveals that memory effects are important in adults but negligible in infants, suggesting that these effects may reflect underlying physiological differences. Overall, this work provides a systematic and interpretable framework for incorporating memory effects into pharmacokinetic modeling, with potential applications to a wide range of drug systems involving complex binding dynamics.

Vertex models are widely used within the field of developmental biology to study tissue morphogenesis. These models are well-suited for modeling deformation at the cellular level where movement is driven by local forces. However, understanding how these microscopic movements coordinate to yield macroscopic phenomena such as the shapes of entire tissues remains a challenge. Here we study a top-down approach using differentiable programming on a simplified vertex model of a laminar tissue, and investigate whether the attributes of individual cells can be tuned to make the mesh as a whole acquire a predefined shape. We let the mesh evolve according to simple rules defined by the input to each polygon, and evaluate the resulting shape against a target boundary. Additionally, we show how the high degeneracy of the output can be reduced by constraining the polygon distributions: first, by adding simple penalties on tissue-wide attributes; and second, by dividing the tissue into regions, within which we bias the attributes toward characteristic values. Our study shows how a simple vertex model can be combined with differentiable programming to model developing tissues, and provides insight into the way individual cells must coordinate to yield macroscopic phenomena such as pre-programmed shapes.

We introduce a mechanistic, nonlocal tumour-growth model designed specifically to capture explosive dynamics that are not adequately explained by standard logistic reaction-diffusion descriptions. The motivation is empirical: the universal scaling law reported in [1] provides compelling cross-sectional evidence of superlinear tumour activity versus tumour burden, but as a phenomenological relationship it does not by itself supply a dynamical mechanism, nor does it rigorously describe how explosive growth emerges, how fast it develops, or how spatial interactions and tissue boundaries influence it. Our model addresses this gap by incorporating nonlocal proliferative feedback--cells respond to a spatially aggregated neighbourhood signal--and a singular, Kawarada-type acceleration that produces "quenching": tumour density stays bounded while the proliferative drive becomes unbounded as the aggregated signal approaches a critical threshold. This offers a concrete mechanistic route to explosive escalation consistent with physical boundedness. We analyse the model under no-flux (Neumann) boundary conditions, appropriate for reflecting tissue interfaces. In the spatially homogeneous setting we prove finite-time onset of the explosive regime and obtain explicit rates for how rapidly it is approached. For spatially heterogeneous perturbations we derive a transparent spectral stability theory showing how the interaction kernel selects spatial scales and how the singular acceleration tightens stability margins as the explosive threshold is approached. These results provide interpretable links between nonlocal interaction structure, boundary effects, and the emergence of rapid growth. Finally, to connect mechanism to data in the spirit of [1], we embed the model in a Bayesian inference framework that treats the interaction kernel and the acceleration strength as unknown and learned from tumour-growth observations. This enables uncertainty-aware estimation of explosive onset times, escalation rates, and stability margins, while positioning the scaling law of [1] as an observable signature that our mechanistic model can explain and quantify rather than merely fit.

Variability in gene expression among single cells and growing cell populations can arise from the stochastic nature of protein synthesis, which often occurs in random bursts. This study investigates the variability in the expression of a growth-sustaining protein, whose concentration is regulated by a negative feedback loop due to cell growth-induced dilution. We model the distribution of protein concentration using a Chapman-Kolmogorov equation for single cells and a population balance equation for growing cell populations. For single cells, we derive an explicit solution for the protein concentration distribution in state space and represent it as a Bessel function in Laplace space. For growing populations, we find that the distribution satisfies a Heun differential equation with singular boundary conditions. By addressing the central connection problem for the Heun equation, we quantify the population-level protein distribution and determine the Mathusian parameter, which characterizes population growth. This work provides a comprehensive analytical framework for understanding how stochastic protein synthesis impacts gene expression variability and population dynamics.

Metabolic networks are typically viewed as homeostatic systems that stabilize flux, energy charge, redox balance, and metabolite availability under perturbation. However, it remains unclear whether the same feedback architectures that support metabolic robustness can also generate learning-like, experience-dependent adaptation. Here, we develop a coarse-grained dynamical model of mammalian energy metabolism to test whether prior perturbation can improve future metabolic responses. The model represents core glucose, glutamine, fatty acid, and oxidative phosphorylation pathways as coupled ordinary differential equations with Michaelis-Menten-type fluxes, product-inhibition feedback, adaptive enzyme-capacity regulation, and explicit ATP costs for enzyme adjustment. Rather than aiming to reproduce quantitative fluxes for a specific cell type, the framework is designed to expose how metabolic feedback, regulatory cost, repeated perturbation, and environmental variability interact. We use this model to ask whether adaptive enzyme regulation enables improved recovery after repeated challenges, whether such effects depend on energetic control costs, and whether environmental variability broadens or constrains the set of reachable adaptive states. This approach provides a tractable way to investigate how homeostatic metabolic regulation may give rise to experience-dependent metabolic plasticity.

The challenge of stratifying patients for combination therapy is both technically demanding and clinically crucial. In previous work, we introduced a multi-objective optimization framework for identifying optimally synergistic combination protocols that are robust to competing definitions of additivity. This manuscript extends this methodology to quantify how inter-individual variability in drug sensitivity influences the combination doses that optimally balance the competing objectives of synergy of efficacy and synergy of potency (a proxy measure of toxicity). For this methodology, we introduce a voxel-based stratification approach to characterize individuals (model parameterizations) into subgroups based on sensitivity to each drug as a monotherapy and in combination. As a case study, we apply the method to a preclinical dataset of murine response to the combination of an immune checkpoint inhibitor and an antiangiogenic agent. We demonstrate that the algorithm can quantify how the robustly optimal combination therapies vary across different treatment response subgroups and how the algorithm can identify subpopulations for which no meaningfully efficacious combination exists. As applying the methodology requires knowledge of specific parameter values for which measurable biomarkers may be unavailable, we also propose an initiation protocol that permits identification of the parameters necessary to place an individual in a subgroup. This methodology is a step in the direction of determining the right combination therapy for a subgroup and finding the right subgroup for an existing therapy.

AO_SCPLOWBSTRACTC_SCPLOWOncolytic viruses provide cancer therapy using replication-competent viruses that selectively infect and lyse tumour cells. Their tumour-specific replication also enables the delivery of targeted, virus-encoded gene products, such as enzymes that activate prodrugs. This dual functionality offers the potential for synergistic effects by combining direct oncolysis with localised drug activation. The interplay between infection, replication, lysis, and gene product delivery remains poorly understood. Here, we introduce a spatially structured, multi-patch model of cancer cells infected by an oncolytic virus engineered to deliver a prodrug-activating enzyme. The spatial system is first represented as a microscopic model and subsequently reduced via spectral dimension reduction techniques. This reduction yields an ordinary differential equation model for a set of coarse-grained variables, which we analyze both without the transgene (OV model) and with the transgene (TOV model). For each case, we compute the basic reproduction number, R0, which determines the conditions for viral spread. Both models exhibit three regimes via transcritical bifurcations: (i) R0 < 0, extinction of both cancer and infected cells; (ii) 0 < R0 [&le;] 1, persistence of cancer cells only; and (iii) R0 > 1, coexistence as a stable node or as a focus. The TOV model, as a difference form the OV model, can undergo periodic oscillations arising from a Hopf-Andronov bifurcation. Notably, oscillation amplitudes can be controlled such that cancer cells largely decrease when drug-induced death is stronger in non-infected cells than in infected ones, enabling effective cancer cells killing while maintaining viral replication and prodrug activation. The qualitative behaviour of the coarse-grained model is shown to be preserved in both the microscopic and spatially explicit models.

Cancer progression following treatment failure is an evolutionary process in which therapy acts as a selection pressure driving Darwinian selection on heritable variation to favor resistant clones. This ability to generate variation, i.e., the cancers evolvability, is a key determinant of how rapidly tumors adapt to therapy. Here, we present an evolutionary game-theoretic model to evaluate how evolvability shapes resistance dynamics under two treatment modalities: targeted therapy and chemotherapy. We first compare cancer populations with fixed evolvabilities: low or high. Targeted therapy imposes a steep selection gradient, enabling rapid resistance evolution, while chemotherapy exerts a flatter gradient but drives tumors toward more extreme resistance strategies. We show that targeted therapy works better in low-evolvability cancers, whereas chemotherapy better controls high-evolvability populations. We then extend the model to incorporate facultative evolvability in which cancer cells dynamically adjust their evolvability in response to therapy-induced stress in which cells fine-tune the trade-off between acquiring higher resistance and limiting the costs of resistance and evolvability. The latter strategy sustains a higher tumor burden than fixed-evolvability populations. To address the challenges of facultative evolvability for therapy efficacy, we develop and simulate an evolutionary double bind using sequential cycles of chemotherapy and targeted therapy. With an appropriate sequence and timing, this strategy can drive cancer cells with facultative evolvability to extinction. Our results highlight the importance of evolvability in shaping treatment response and underscore the need to incorporate evolutionary principles into therapy design.

Price equation and genotype dynamics are two methods for studying the fixation of one allele by natural selection in a diploid population. There are two strict monotonicity conditions that imply the fixation of one allele. The genotype dynamics is called Haldane monotone if the relative frequency of one allele strictly increases along all solutions of the genotype dynamics, so this allele is fixed. In this paper, we show that the genotype dynamics is Haldane monotone if and only if the right-hand side of the Price equation is always strictly positive. The other strict monotonicity condition requires that the relative frequency of a homozygote strictly increase according to the genotype dynamics. For example, in a model where the genotype dynamics is governed by interactions between individuals, the cost-accepting homozygote is fixed by natural selection if the other genotypes always receive a smaller average gain from all interactions than the cost-accepting homozygote. Both monotonicity conditions require that the interaction is not well-mixed in the population. These two conditions are not equivalent. In addition, we give a non-monotonicity condition, which also implies the fixation of a homozygote. The fixation of a homozygote depends on the phenotypic payoff of the interaction, the genotype-phenotype mapping, and the interaction scheme. In a sexual population, the interaction scheme of siblings depends on the mating system, and so do the conditions of fixation of the cost-accepting homozygote. We present examples showing that if we only change the monogamous mating system, assuming panmixing or mating assortativity, then the condition for the fixation of the cooperator homozygote is b > 2c and b > c, respectively.

Cytokine-mediated communication is a central mechanism by which immune cells coordinate activation, differentiation and proliferation. While mechanistic reaction-diffusion models provide detailed descriptions of cytokine secretion and uptake at the cellular scale, their computational cost limits their applicability to large and densely packed cell populations. Previously employed approximations of cytokine diffusion fields rely on assumptions that neglect the influence of cellular geometry and volume exclusion. In this work, we study a macroscopic description of cytokine diffusion and reaction dynamics based on homogenization techniques, rigorously linking microscopic reaction-diffusion formulations to effective continuum models. The resulting homogenized equations replace discrete responder cells with a continuous density, while retaining essential features of cellular uptake and excluded-volume effects. Further, we show that in regimes with approximate radial symmetry, classical Yukawa-type solutions emerge as limiting cases of the homogenized model, provided appropriate correction factors are included. Overall, our approach allows efficient multiscale modeling of cytokine signaling in complex immune-cell environments.

Minimum viable populations (MVPs) are population levels large enough to surmount risk from demographic, environmental, and genetic stochasticity. MVPs are estimated by biologists to guide conservation practices. However, MVPs are generally estimated for a target population without regard for how they interact with intra- and inter-species population dynamics in the broader ecological community. Thus, how and why population dynamics interact with MVPs imposed by conservation biologists remain unclear. When MVPs are imposed on a continuous population model, traditional analyses fail to capture the range of possible outcomes those MVPs create. Here, we describe viability space decomposition (VSD) as a mathematical tool to systematically analyze the potential crossing of MVPs during population dynamics. We demonstrate that different extinction and survival outcomes can be recovered from a model with imposed MVPs using three VSD concepts in junction with a traditional phase portrait: mortality manifolds which separate conditions that lead to different existential outcomes, ordering manifolds which determine the order of extinction events for multiple populations, and collapse manifolds which determine the survival or extinction of one species given the loss of another. We employ these methods with a standard consumer-resource model, and the methods can be scaled to systems with more species. VSD is a useful tool for conservation biologists and community ecologists concerned with boundary crossing problems in any dynamical system.

Neuronal activity alters extracellular ion concentrations and electric potentials. Ephaptic effects refer to the feedback influence that these extracellular changes can have on neuronal activity. While electric ephaptic effects occur on a fast timescale due to extracellular potential perturbations, ionic ephaptic effects are driven by slower, accumulative changes in ion concentrations. Among the previous computational studies of ephaptic effects, the vast majority have focused exclusively on electric effects, while ionic ephaptic effects have largely been neglected. In this work, we present an electrodiffusive computational framework consisting of two-compartment neurons that interact via a shared extracellular space. By accounting for both electric potentials and ion-concentration dynamics in a self-consistent manner, our framework enables us to explore the relative roles of electric and ionic ephaptic effects. Through numerical experiments, we demonstrate that ionic and electric ephaptic interactions play very different roles. While ionic ephaptic interactions increase population firing rates, electric ephaptic interactions primarily drive subtle shifts in spike timing. Furthermore, we show that these spike shifts cause the phase difference (the distance in spike times between a small collection of neurons) to converge to a stable, unique phase difference, which we coin the ephaptic intrinsic phase preference. Author summaryNeurons predominantly communicate through synapses: specialized contact points where a brief electrical signal, known as a spike or action potential, in one neuron influences another. Neurons generate these spikes by exchanging ions with the surrounding extracellular space. This way, spiking neurons alter extracellular ion concentrations and electric potentials. Since neurons are sensitive to such changes in their environment, they can also influence one another indirectly through the shared extracellular medium. This form of non-synaptic interaction is known as ephaptic coupling. Most computational models of neuronal activity neglect ephaptic interactions, and those that include them typically consider only electric effects while ignoring ionic contributions. As a result, the relative roles of electric and ionic ephaptic effects remain poorly understood. Here, we introduce a computational framework that accounts for both mechanisms in a self-consistent way. Our results show a functional distinction: ionic ephaptic effects act slowly, regulating population firing rates, whereas electric ephaptic effects act on millisecond timescales and subtly shift spike timing. These shifts cause spike-time differences between neurons to converge to a stable value, a phenomenon we call ephaptic intrinsic phase preference.

Ordinary differential equation models of biochemical reactions are often formulated as stoichiometric systems in which the dynamics arise from a collection of interacting processes. A central challenge is that the functional form of each process is rarely known a priori and may be difficult to infer from data. We propose biochemically informed neural ordinary differential equations (BINODEs), a neural-ODE framework that retains the stoichiometric structure of mechanistic models while representing individual processes by neural networks. In BINODEs, the outputs of neural network processes (NNPs) are mapped to state derivatives through a linear layer analogous to a stoichiometric matrix. This architecture allows biological side information, such as process-specific inputs, sign constraints, and monotonicity assumptions, to be built directly into the model. We characterize the approximation properties of NNPs for several standard biochemical rate laws and show that the proposed framework recovers both trajectories and process-level structure in Monod, Lotka-Volterra, pharmacokinetic, and ultradian endocrine models. These results suggest that BINODEs offer a useful compromise between mechanistic interpretability and data-driven flexibility for modeling partially known biochemical or biological dynamical systems.